Literature DB >> 11026972

Anterior optic nerve microvascular changes in human glaucomatous optic neuropathy.

D Y Zhao1, G A Cioffi.   

Abstract

The microvascular changes in the anterior optic nerve in human glaucomatous eyes were examined by selective methylmethacrylate microvascular corrosion castings following cannulation of the central retinal artery and posterior ciliary arteries in 11 normal eyes and 9 glaucomatous eyes. The resulting castings were examined with scanning electron microscopy. Microvascular changes were found in the anterior optic nerves of all the glaucomatous eyes with visual function loss. These findings include areas of capillary filling defects within the anterior optic nerve and a decreased numbers of feeding arteriolar vessels to the anterior optic nerve. In the prelaminar and laminar regions, the typical capillary patterns are lost and laminar striations are not present. Juxtapapillary choroidal and retinal avascular areas were also identified in two of the glaucomatous eyes. Selective microvascular corrosion casting is an excellent method to examine the three-dimensional microvasculature of the anterior optic nerve. Microvascular changes in the anterior optic nerve may play a role in the development of glaucomatous optic neuropathy.

Entities:  

Mesh:

Year:  2000        PMID: 11026972     DOI: 10.1038/eye.2000.129

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

1.  Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action.

Authors:  Grace C Shih; David J Calkins
Journal:  Expert Rev Ophthalmol       Date:  2012-04

2.  Optical microangiography provides correlation between microstructure and microvasculature of optic nerve head in human subjects.

Authors:  Lin An; Murray Johnstone; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2012-11       Impact factor: 3.170

3.  Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.

Authors:  Rajendra S Kadam; Gajanan Jadhav; Miller Ogidigben; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2011-06-14       Impact factor: 3.922

4.  User-guided segmentation for volumetric retinal optical coherence tomography images.

Authors:  Xin Yin; Jennifer R Chao; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2014-08       Impact factor: 3.170

5.  A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.

Authors:  P G Watson; M F Barnett; V Parker; J Haybittle
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

Review 6.  Pharmacological neuroprotection for glaucoma.

Authors:  Glyn Chidlow; John P M Wood; Robert J Casson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  A Workflow for Three-Dimensional Reconstruction and Quantification of the Monkey Optic Nerve Head Vascular Network.

Authors:  Po-Yi Lee; Yi Hua; Bryn L Brazile; Bin Yang; Lin Wang; Ian A Sigal
Journal:  J Biomech Eng       Date:  2022-06-01       Impact factor: 1.899

8.  Basal blood flow and autoregulation changes in the optic nerve of rhesus monkeys with idiopathic bilateral optic atrophy.

Authors:  Chelsea Piper; Brad Fortune; Grant Cull; George A Cioffi; Lin Wang
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-23       Impact factor: 4.799

9.  Prolonged postocclusive hyperemia response in patients with normal-tension glaucoma.

Authors:  Joanna Wierzbowska; Stanisław Wojtkiewicz; Anna Zbieć; Robert Wierzbowski; Adam Liebert; Roman Maniewski
Journal:  Med Sci Monit       Date:  2014-12-11

10.  Optical coherence tomography angiography of the macula and optic nerve head: microvascular density and test-retest repeatability in normal subjects.

Authors:  Ching Wei Lim; Jun Cheng; Elton Lik Tong Tay; Hwei Yee Teo; Elizabeth Poh Ying Wong; Vernon Khet Yau Yong; Boon Ang Lim; Owen Kim Hee; Hon Tym Wong; Leonard Wei Leon Yip
Journal:  BMC Ophthalmol       Date:  2018-12-10       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.